期刊论文详细信息
Diagnostic Pathology
Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma
Karin Jirström1  Jacob Elebro2 
[1] Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Skåne University Hospital, Lund SE-221 85, Sweden;Skåne University and Regional Laboratories, Lund, Sweden
关键词: Prognosis;    Pancreaticoduodenectomy;    Surgical;    Pathology;    Duodenal neoplasms;    Common bile duct neoplasms;    Pancreatic ductal;    Carcinoma;   
Others  :  801947
DOI  :  10.1186/1746-1596-9-80
 received in 2014-02-05, accepted in 2014-04-01,  发布年份 2014
PDF
【 摘 要 】

Background

Variability in reported histopathology parameters in operated periampullary adenocarcinomas may affect the prognostic weight of the parameters. Standardized axial sectioning produces a higher incidence of involved margins and also seems to produce a lower relative incidence of pancreatic compared with distal bile duct origin and a higher incidence of involved lymph nodes, compared with non-standardized procedure. The aims of this study were to 1) assess how a previously not described standardized pathology procedure, with longitudinal sectioning along the distal bile duct, affects reported tumour origin, margin status and involved lymph nodes, compared with non-standardized procedure, 2) assess if re-evaluation of microscopic slides affects the prognostic value of margin status and 3) compare the results of this standardized procedure with reported results of other standardized and non-standardized procedures.

Methods

One hundred seventy-five consecutive pancreaticoduodenectomy specimens with primary adenocarcinomas, operated during 2001 – 2011 at the University hospitals of Lund and Malmö, Sweden, were re-evaluated histologically, and parameters relevant for classification and prognosis were assessed, with 1 mm as a threshold for involved or uninvolved margins. Follow-up lasted until 31 December 2013. Five-year overall survival (OS) and hazard ratios (HR) were calculated for the margin status stated in the original reports and margin status after re-evaluation.

Results

Compared with non-standardized cases (n = 129), standardized cases (n = 46) had more involved lymph nodes in the specimens (median 3 vs 1), a higher fraction of distal bile duct origin (39% vs 21%) and a higher fraction of involved margins (74% vs 47%). The prognostic value of uninvolved margins increased by re-evaluation of slides (p < 0.001) and the adjusted HR for involved margins increased from 1.6 (95% CI 1.1 - 2.4) to 3.3 (95% CI 1.5 – 7.0). Uninvolved margins remained a significant predictor of OS in adjusted analysis.

Conclusions

Both the method of sectioning the specimen and the microscopic assessment affect prognostic pathology parameters significantly. The results of the herein described standardized method are similar to the results of other standardized procedures. The 1-mm threshold for involved margins in pancreaticoduodenectomies is relevant for OS, and margin status is an independent prognostic parameter.

Virtual slides

The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1056639379120615 webcite

【 授权许可】

   
2014 Elebro and Jirström; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140708014022401.pdf 1401KB PDF download
Figure 2. 68KB Image download
Figure 1. 235KB Image download
【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】
  • [1]Verbeke CS: Resection margins and R1 rates in pancreatic cancer–are we there yet? Histopathology 2008, 52:787-796.
  • [2]Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A: Redefining the R1 resection in pancreatic cancer. Br J Surg 2006, 93:1232-1237.
  • [3]Menon KV, Gomez D, Smith AM, Anthoney A, Verbeke CS: Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB (Oxford) 2009, 11:18-24.
  • [4]Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M: Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol 2010, 17:991-997.
  • [5]Jarufe NP, Coldham C, Mayer AD, Mirza DF, Buckels JA, Bramhall SR: Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 2004, 21:202-209.
  • [6]Allema JH, Reinders ME, van Gulik TM, Koelemay MJ, Van Leeuwen DJ, de Wit LT, Gouma DJ, Obertop H: Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 2069–2076, 1995:75.
  • [7]Riall TS, Cameron JL, Lillemoe KD, Winter JM, Campbell KA, Hruban RH, Chang D, Yeo CJ: Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 2006, 140:764-772.
  • [8]van Roest MH, Gouw AS, Peeters PM, Porte RJ, Slooff MJ, Fidler V, de Jong KP: Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization. Ann Surg 2008, 248:97-103.
  • [9]van Geenen RC, van Gulik TM, Offerhaus GJ, de Wit LT, Busch OR, Obertop H, Gouma DJ: Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. Eur J Surg Oncol 2001, 27:549-557.
  • [10]Schmidt CM, Powell ES, Yiannoutsos CT, Howard TJ, Wiebke EA, Wiesenauer CA, Baumgardner JA, Cummings OW, Jacobson LE, Broadie TA, Canal DF, Goulet RJ Jr, Curie EA, Cardenes H, Watkins JM, Loehrer PJ, Lillemoe KD, Madura JA: Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 2004, 139:718-727.
  • [11]Verbeke CS, Gladhaug IP: Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg 2012, 99:1036-1049.
  • [12]Campbell F, Bennett MK, Foulis AK: Standards and minimum datasets for reporting cancers. Minimum dataset for the histopathological reporting of pancreatic, ampulla of Vater and bile duct carcinoma. London: The Royal College of Pathologists; 2002.
  • [13]Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, Esaki Y: Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res 1994, 85:161-166.
  • [14]Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP: Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC cancer 2008, 8:170. BioMed Central Full Text
  • [15]Fischer HP, Zhou H: Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004, 11:301-309.
  • [16]Wang T, Liang YM, Hu P, Cheng YF: Mucins differently expressed in various ampullary adenocarcinomas. Diagn Pathol 2011, 6:102. BioMed Central Full Text
  • [17]Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP: Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC cancer 2008, 8:5. BioMed Central Full Text
  • [18]Rau BM, Moritz K, Schuschan S, Alsfasser G, Prall F, Klar E: R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery 2012, 152:S103-111.
  文献评价指标  
  下载次数:34次 浏览次数:20次